Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000356334

Medchemexpress LLC YK-4-279 | 1037184-44-3 | 99.9% | C17H13Cl2NO4 | 1 ML
SDP

Catalog No. 5000356334
Encompass_Preferred

YK-4-279 is an inhibitor that blocks RNA Helicase A (RHA) binding with EWS-FLI1, an oncogenic protein. It induces apoptosis and exhibits anti-proliferation activities against various cancer cells. This compound contains a chiral center and can be separated into two enantiomers, making it suitable for cancer research.

  • Blocks RNA Helicase A (RHA) binding with EWS-FLI1
  • Induces apoptosis
  • Exhibits anti-proliferation activities against various cancer cells
  • Contains a chiral center
  • Can be separated into two enantiomers
  • Used in cancer research

Catalog No. 50-003-56334 Supplier Medchemexpress LLC Supplier No. HY1450710MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

YK-4-279 is an inhibitor that blocks RNA Helicase A (RHA) binding with EWS-FLI1, an oncogenic protein. It induces apoptosis and exhibits anti-proliferation activities against various cancer cells. This compound contains a chiral center and can be separated into two enantiomers, making it suitable for cancer research.

  • Blocks RNA Helicase A (RHA) binding with EWS-FLI1
  • Induces apoptosis
  • Exhibits anti-proliferation activities against various cancer cells
  • Contains a chiral center
  • Can be separated into two enantiomers
  • Used in cancer research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.